- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Live from the 2022 American Academy of Dermatology Annual Meeting
Author(s):
The American Academy of Dermatology Annual meeting starts today, offering presentations focusing on the latest treatment updates, new data, plus much more.
The 2022 American Academy of Dermatology (AAD) Annual meeting starts March 25 with a multitude of presentations and will conclude on March 29.
The annual meeting is live and in person for the first time since 2019, giving participants the opportunity to reconnect with peers.
“You’ll find hundreds of educational sessions covering the breadth of the specialty, with a mix of new sessions and old favorites,” according to the AAD website.“You’ll see industry showing off the latest and greatest things in a bustling exhibit hall.”
Highlights from the agenda include:
The 2022 Debates: Controversies in Dermatology
New devices, therapies, socio-economic and political factors, as well as new ways of thinking about our profession produce controversy. This session is designed for interactive discussion of the issues that we are actively encountering in 2022.
Jak Inhibitors: A New Frontier in Dermatology
The application of JAK inhibitors to common dermatologic diseases will be presented, including the results of clinical trials and case series. Safety will be discussed in detail. The audience for this session will be dermatologists who care for patients with alopecia areata, vitiligo, atopic dermatitis, psoriasis, granuloma annulare and sarcoidosis, morphea, and dermatomyositis, in addition to other conditions.
Late-Breaking Research: Clinical Trials
Investigators can submit abstracts describing their most recent unpublished results in clinical trials. After a competitive review, the top-scoring studies will be invited to discuss their findings in a brief oral presentation. Together with the other Late Breaking Abstract sessions, these forums and symposium will highlight the latest ground-breaking observations in all aspects of dermatological research.
COVID-19 Dermatology and Vaccines
This symposium will serve as an overview of key topics in COVID-19 Dermatology, ranging from COVID skin manifestations, post-acute dermatologic sequelae of COVID-19, COVID-19 and skin of color, COVID-19 vaccines, COVID-19 and biologics, and effects of COVID on dermatology training and practice. This session is anchored by expert speakers from the AAD Ad Hoc Task Force on COVID-19.
See the full agenda here.
Make sure to keep up to date with the latest in coverage from the event and subscribe to Dermatology Times® to receive daily conference recaps.
